Enveric Biosciences (ENVB) Stock Chart & Stock Price History → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free ENVB Stock Alerts $0.89 -0.03 (-3.26%) (As of 05/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Enveric Biosciences Stock Price Performance5 Day Performance-3.84%1 Month Performance-4.30%3 Month Performance+8.90%6 Month Performance-50.56%Year-To-Date Performance-31.54%1 Year Performance-56.37% Receive ENVB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. ENVB Stock Chart for Wednesday, May, 8, 2024 ENVB Chart by TradingView Enveric Biosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$0.92$0.89-3.26%$0.94$0.8892,147 shs$6.49 million05/06/2024$0.98$0.92-6.12%$0.98$0.9090,976 shs$6.71 million05/03/2024$0.93$0.98+5.89%$1.02$0.92203,914 shs$7.14 million05/02/2024$0.93$0.93-0.46%$0.95$0.91144,883 shs$6.75 million05/01/2024$0.94$0.93-1.09%$0.96$0.90109,485 shs$6.78 million04/30/2024$0.95$0.94-1.03%$0.96$0.92161,379 shs$6.85 million Get the Latest News and Ratings for ENVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$0.90$0.95+6.12%$0.95$0.9155,253 shs$6.92 million04/26/2024$0.92$0.90-2.45%$0.94$0.9057,769 shs$6.53 million04/25/2024$0.93$0.92-1.77%$0.96$0.8888,599 shs$6.69 million04/24/2024$0.90$0.93+4.08%$0.98$0.88183,673 shs$6.81 million04/23/2024$0.86$0.90+4.23%$0.90$0.8670,822 shs$6.54 million04/22/2024$0.88$0.86-2.23%$0.89$0.86108,811 shs$6.28 million04/19/2024$0.94$0.88-6.12%$0.95$0.88126,289 shs$6.42 million04/18/2024$0.88$0.94+6.35%$0.96$0.9089,310 shs$6.84 million04/17/2024$0.91$0.88-3.18%$0.96$0.8881,992 shs$6.43 million04/16/2024$0.92$0.91-1.14%$0.95$0.89114,527 shs$6.64 million04/15/2024$1.01$0.92-8.76%$1.03$0.91165,141 shs$6.72 million04/12/2024$0.91$1.01+10.95%$1.03$0.92382,892 shs$7.36 million04/11/2024$0.93$0.91-1.93%$0.95$0.9061,623 shs$6.64 million04/10/2024$0.94$0.93-1.38%$0.95$0.8947,882 shs$6.77 million04/09/2024$0.92$0.94+2.29%$0.99$0.90108,215 shs$6.86 million04/08/2024$0.93$0.92-1.06%$0.96$0.9187,380 shs$6.71 million04/05/2024$0.95$0.93-2.21%$0.99$0.8989,892 shs$5.02 million04/04/2024$1.01$0.95-5.84%$1.00$0.95154,153 shs$5.14 million04/03/2024$1.14$1.01-11.40%$1.05$0.89599,957 shs$5.45 million04/02/2024$0.89$1.14+28.09%$1.19$0.831.55 million shs$6.16 million04/01/2024$1.00$0.89-11.00%$1.00$0.88454,398 shs$4.81 million03/29/2024$1.00$1.00$1.04$1.00268,386 shs$5.40 million03/28/2024$1.02$1.00-1.96%$1.04$1.00266,677 shs$5.40 million03/27/2024$1.06$1.02-3.77%$1.04$1.00384,787 shs$5.51 million03/26/2024$1.05$1.06+0.95%$1.08$1.02304,540 shs$5.72 million03/25/2024$1.13$1.05-7.08%$1.16$1.03443,641 shs$5.67 million03/22/2024$1.17$1.13-3.42%$1.20$1.11294,045 shs$6.10 million03/21/2024$1.17$1.17$1.23$1.10833,356 shs$6.32 million03/20/2024$1.19$1.17-1.68%$1.27$1.082.42 million shs$6.32 million03/19/2024$1.10$1.19+8.18%$1.87$1.1151.85 million shs$6.43 million03/18/2024$1.08$1.10+1.85%$1.12$1.06139,393 shs$5.94 million03/15/2024$1.10$1.08-1.82%$1.15$1.08124,865 shs$2.96 million03/14/2024$1.16$1.10-5.17%$1.10$1.05213,173 shs$3.01 million03/13/2024$1.20$1.16-3.33%$1.23$1.01293,402 shs$3.18 millionThe new financial threat that could wipe out millions… (Ad)During the Internet boom, companies like Pets.com were supposed to be promising investments riding the wave of a new tech boom. But then they were gone within a blink of an eye. One of the most successful investors in history just stepped forward to say the same thing is about to happen to AI stocks.Pay close attention to this important video03/12/2024$1.32$1.20-9.09%$1.37$1.14636,219 shs$3.29 million03/11/2024$1.41$1.32-6.38%$1.51$1.28291,120 shs$3.62 million03/08/2024$1.52$1.41-7.24%$1.56$1.40268,665 shs$3.86 million03/07/2024$1.38$1.52+10.14%$1.63$1.28602,556 shs$4.17 million03/06/2024$1.41$1.38-2.13%$1.45$1.25554,119 shs$3.78 million03/05/2024$1.55$1.41-9.03%$1.55$1.40657,586 shs$3.86 million03/04/2024$1.66$1.55-6.63%$1.60$1.401.39 million shs$4.25 million03/01/2024$1.45$1.66+14.48%$1.90$1.4513.64 million shs$4.55 million02/29/2024$0.83$1.45+74.49%$2.92$1.32176.77 million shs$3.97 million02/28/2024$0.84$0.83-1.07%$0.90$0.8376,985 shs$2.28 million02/27/2024$0.85$0.84-1.34%$0.95$0.81273,556 shs$2.30 million02/26/2024$0.98$0.85-13.12%$0.95$0.84478,063 shs$2.33 million02/23/2024$0.86$0.98+14.09%$1.27$0.9313.21 million shs$2.69 million02/22/2024$0.86$0.86+0.23%$0.89$0.8426,926 shs$2.35 million02/21/2024$0.87$0.86-1.03%$0.91$0.83103,286 shs$2.35 million02/20/2024$0.83$0.87+4.20%$0.89$0.8063,376 shs$2.37 million02/19/2024$0.83$0.83$0.84$0.808,400 shs$2.28 million02/16/2024$0.84$0.82-2.01%$0.84$0.817,247 shs$2.25 million02/15/2024$0.82$0.84+1.71%$0.84$0.8126,303 shs$2.30 million02/14/2024$0.82$0.82+1.21%$0.83$0.7814,397 shs$2.26 million02/13/2024$0.81$0.82+0.74%$0.82$0.7818,480 shs$2.23 million02/12/2024$0.77$0.81+5.02%$0.84$0.7798,110 shs$2.22 million02/09/2024$0.81$0.77-5.10%$0.85$0.7733,009 shs$2.11 million02/08/2024$0.82$0.81-0.69%$0.83$0.7734,523 shs$2.22 million02/07/2024$0.85$0.82-3.37%$0.83$0.76140,196 shs$2.24 million02/06/2024$0.85$0.85-0.62%$1.14$0.791.24 million shs$2.32 million Related Companies: HILS Stock Price Chart KA Stock Price Chart AIMD Stock Price Chart LIXT Stock Price Chart YMTX Stock Price Chart ASLN Stock Price Chart ADIL Stock Price Chart PULM Stock Price Chart TENX Stock Price Chart OGEN Stock Price Chart Receive ENVB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENVB) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorStock-Picking AI Predicts #1 Stock of 2024Altimetry[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.